# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001714899-21-000106
Filing Date
2021-11-04
Accepted
2021-11-04 16:07:01
Documents
61
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | dnli-20210930.htm iXBRL | 10-Q | 1854499
2 | EX-31.1 | exhibit311q32021.htm | EX-31.1 | 9998
3 | EX-31.2 | exhibit312q32021.htm | EX-31.2 | 9996
4 | EX-32.1 | exhibit321q32021.htm | EX-32.1 | 5661
5 | EX-32.2 | exhibit322q32021.htm | EX-32.2 | 5768
| Complete submission text file | 0001714899-21-000106.txt |  | 6733702

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | dnli-20210930.xsd | EX-101.SCH | 38749
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | dnli-20210930_cal.xml | EX-101.CAL | 56569
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | dnli-20210930_def.xml | EX-101.DEF | 169805
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | dnli-20210930_lab.xml | EX-101.LAB | 493157
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | dnli-20210930_pre.xml | EX-101.PRE | 321992
11 | EXTRACTED XBRL INSTANCE DOCUMENT | dnli-20210930_htm.xml | XML | 1150916

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38311 | Film No.: 211379927
SIC: 2836 Biological Products, (No Diagnostic Substances)